Clinical Trials at Cleveland Clinic Florida
As of August 2026, 33 paid clinical trials are recruiting at Cleveland Clinic Florida, located at 2950 CLEVELAND CLINIC BLVD, WESTON, FL 33331, phone (954) 659-5359 in Weston, Florida. Active studies at this site cover conditions such as Breast Cancer, Obesity and Overweight. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Weston
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
34 clinical trials at Cleveland Clinic Florida
·Clear filters·A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Caris Biorepository Research Protocol
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
At-Home Bowel Stimulation
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer
Global Cardio Oncology Registry
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System
Cardiogenic Shock Working Group Registry
ColoSeal™ ICD System Anastomotic Protection Pivotal Study
Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
Common conditions studied in Weston
- Breast Cancer (6 active studies)
- Obesity (5 active studies)
- Overweight (5 active studies)
- Diabetes Mellitus, Type 2 (4 active studies)
- Acute Kidney Injury (3 active studies)
- Cancer (3 active studies)
Leading research sponsors in Weston
- The Cleveland Clinic
- Novo Nordisk A/S
- AbbVie
- Case Comprehensive Cancer Center
- Hoffmann-La Roche
Frequently asked questions
How many paid clinical trials are currently recruiting in Weston?
There are approximately 98 recruiting clinical trials in Weston, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Weston pay participants?
Most recruiting trials in Weston compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Weston?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Weston?
The most common conditions under active study in Weston include Breast Cancer (6), Obesity (5), Overweight (5), Diabetes Mellitus, Type 2 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Weston?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Weston on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Weston?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Weston?
Recruiting research sites in Weston include Cleveland Clinic Florida, Cleveland Clinic-Weston, Encore Medical Research - Weston, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Weston right now?
The largest active categories in Weston are Cancer & tumors (33), Cardiovascular (13), Diabetes & metabolic (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Cleveland Clinic Florida?
Cleveland Clinic Florida is located at 2950 CLEVELAND CLINIC BLVD, WESTON, FL 33331. Use the Google Maps link in the intro above to get directions.
How do I contact Cleveland Clinic Florida?
You can reach Cleveland Clinic Florida by phone at (954) 659-5359. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.